eGFR >60 | CKD stage 3 | p Value | |
---|---|---|---|
n | 840 | 93 | |
Age (years) | 61 (59 to 61) | 71 (69 to 73) | <0.001 |
Gender (n; % male) | 546 (65) | 69 (74) | 0.08 |
BMI (kg/m2) | 26.7 (26.3 to 27.1) | 27.4 (26.3 to 28.5) | 0.24 |
Cancer (n (%)) | 360 (43) | 34 (37) | 0.34 |
Ischaemic heart disease (n (%)) | 156 (19) | 24 (26) | 0.08 |
Hypertension (n (%)) | 252 (30) | 51 (55) | <0.001 |
Heart failure (n (%)) | 44 (5) | 4 (4) | 0.44 |
CVA/TIA (n (%)) | 20 (2) | 4 (4) | 0.31 |
Diabetes mellitus (n (%)) | 71 (9) | 20 (22) | <0.001 |
Haemoglobin (g/dL) | 13.3 (13.0 to 13.5) | 12.9 (12.5 to 13.3) | 0.39 |
Albumin (g/L) | 44±4 | 44±4 | 0.81 |
Lung disease/COPD (n (%)) | 98 (13) | 15 (16) | 0.49 |
Smoker (ex/present; n (%) | 291 (35) | 36 (39) | 0.55 |
β-blocker (n (%)) | 85 (10) | 13 (14) | 0.20 |
Nitrate (n (%)) | 24 (3) | 5 (5) | 0.16 |
ACE inhibitor (n (%)) | 119 (14) | 26 (28) | <0.001 |
Statin (n (%)) | 184 (22) | 34 (37) | <0.001 |
Data are shown as n (%) or mean (95% CIs).
BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; eGFR, estimated glomerular filtration rate; TIA, transient ischemic attack.